Cervical Cancer

Treatment with an investigational cancer vaccine plus Tecentriq was associated with positive outcomes in patients with heavily pre-treated advanced cervical cancer, according to findings from an interim analysis of a phase 2 trial.

AstraZeneca, the manufacturer of the drug, announced that treatment with Imfinzi plus chemoradiotherapy did not improve survival compared with standard-of-care chemoradiotherapy alone in patients with locally advanced cervical cancer.

With newer treatments like Keytruda (pembrolizumab) approved for patients with cervical cancer, a younger patient population may be concerned about experiencing side effects that interrupt their lives — but if they occur, clinicians will be ready with a plan for management, says an expert from the Uniformed Services University of the Health Sciences.

In this episode of the “Cancer Horizons” podcast, a cervical cancer survivor and advocate explains how she navigated being given six to 24 months to live as a single mother of three children and no health insurance.

One woman explains how after experiencing irregular bleeding, she found out she had cervical cancer and her life changed immediately.

The Food and Drug Administration is expected to decide on whether to approve certain cancer regimens within the first few months of the year. Here’s what patients with cancer should know.

The antibody drug conjugate could provide patients with symptomatic relief, along with manageable side effects.

Tivdak is a targeted therapy that showed promising results for patients with pretreated metastatic or recurrent cervical cancer.

Transvaginal ultrasonography may inaccurately measure uterine lining in Black women, highlighting the potential to assess its use on a case-by-case basis.

Pap tests should be replaced by more accurate HPV DNA tests, the organization says.

From a dance tribute performed by Kevin Boseman, late actor Chadwick Boseman’s brother to the humorous coloring book a woman created during treatment for cancer, here’s what’s happening in the cancer landscape this week.

Treatment with chemotherapy following the standard chemoradiation treatment failed to improve multiple survival outcomes in women with locally advanced cervical cancer.

Almost 20 years of data indicate that the incidence of HPV-related cervical cancer is noticeably declining, however other cancers related to the virus continue, and are expected, to increase.

Treatment with tisotumab vedotin, a novel antibody-drug conjugate, in women with recurrent or metastatic cervical cancer, led to an objective response rate of 24% with a manageable safety profile.

The HPV vaccine has been shown to help prevent cervical cancer, but what if you didn’t get the vaccine in time to prevent the disease?

On social media, CURE® recently asked its readers to share their thoughts on getting the HPV vaccine to help prevent certain types of cancer later in life. Here is what some of them shared.

From study results demonstrating that the HPV vaccine substantially reduces the risk of cervical cancer to the first person known to be cured of HIV dying from acute myeloid leukemia, here’s what’s happening in the cancer landscape this week.

The Food and Drug Administration approved the expanded use of the biomarker test CINtec PLUS Cytology that looks at HPV related biomarkers that could lead to cervical cancer. This is the first triage test approved in this space.

Make sure to prioritize your family health history to understand your risk of cancer.

Immunotherapy used after chemoradiotherapy shows better survival outcomes for patients with cervical cancer.

New biological advances are giving patients and their care teams a better understanding of cervical cancer — a disease that affects thousands each year.

Women who use copper intrauterine devices (IUD) as a form of birth control may be at lower risk for high-grade cervical cancer compared with those who use a levonorgestrel-releasing intrauterine system.

The World Health Organization has announced a vaccination-based initiative to eliminate cervical cancer as a public health problem in low to middle income countries.

For World Cancer Day, here are 6 hot topics making an impact in the cancer space.

Here is a list of clinical trials that are currently happening within the cervical cancer space.